Skip to main content

Archive

Would you like to join the Diversity in Research group?

Article published: 19 Sep, 2024

NIHR Oxford Health Biomedical Research Centre (OH BRC) and NIHR Oxford Biomedical Research Centre (OBRC) are seeking committed individuals to join their Diversity in Research Group to share experiences and ideas related to health.

Which drugs are the most effective for acute migraines?

Article published: 19 Sep, 2024

Triptans, a drug usually offered as an alternative to painkillers, have been found to be the most effective medicine for adults who experience acute migraines. Findings of a study, which … Read more

Oxford Health Biomedical Research Centre (OH BRC) September Newsletter now available

Article published: 16 Sep, 2024

The September issue of the OH BRC Newsletter is now available to read on the OH BRC website.

Oxford Health R&D staff talk about studies at Dementia Oxfordshire event

Article published: 13 Sep, 2024

Research staff at Oxford Health recently attended the Autumn Information Fayre at the Windmill Centre in Deddington to provide information opportunities to take part in dementia research.

Oxford Academic Health Partners announces new Board chair

Article published: 11 Sep, 2024

Professor Sir Jonathan Montgomery has been appointed as the new chair of the Board of the Oxford Academic Health Partners (OAHP).

Participants report positive experiences of taking part in health research

Article published: 9 Sep, 2024

Around nine in ten research participants in the Thames Valley area said that they would take part in another study in the future.

Sports concussions in non-athletes not linked to long-term cognitive effects – new study

Article published: 6 Sep, 2024

The impact of concussion while playing sport is different in those who don’t play professionally, according to new research.

How do social skills affect daily life for people with Alzheimer’s dementia?

Article published: 4 Sep, 2024

Participants are being recruited for the Social Cognition and Functioning in Alzheimer’s Dementia (SOCIAL) study at Oxford Health NHS Foundation Trust.

Oxford Health psychiatrist awarded £2.4 million Wellcome Career Development Award

Article published: 2 Sep, 2024

Dr Anya Topiwala, consultant psychiatrist at the Trust and Wellcome Clinical Career Development Fellow at the University of Oxford’s Big Data Institute, has been awarded a £2.4 million Wellcome Career Development Award to grow her research team.

New drug to treat patients in the early stages of Alzheimer’s

Article published: 23 Aug, 2024

This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of Alzheimer’s disease.